Researchers Identify New Therapeutic Target For Metastatic Prostate Cancer | Latest News RSS feed

Researchers Identify New Therapeutic Target For Metastatic Prostate Cancer - Latest News

FDA approves Bayer's Nubeqa® (darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer

4 PSA monitoring is important to identify ... Prostate Cancer Foundation (PCF). "For 26 years, PCF has been focused on research aimed at improving patient outcomes and we welcome the addition of ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Researchers identify new therapeutic target for metastatic prostate cancer

Researchers in New York have found that treating human prostate cancer cells with a drug that targets a protein called PHLPP2 may prevent the cancer cells from spreading to other organs in the body. read more

Metastatic Prostate Cancer Target Identified for Combo Therapy

Scientists in the U.S., Spain, and Switzerland have identified a protein that could represent a new target ... cancer,” may offer promising treatments for metastatic prostate cancer. The researchers ... read more

Looking for another news?

Researchers investigate new targeted therapy for metastatic prostate cancer

At 12 centers across Germany, a total of 145 patients, between 43 and 88 years in age, were treated with one to four cycles of the therapy. All the patients had metastatic ... allows researchers to ... read more

U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer

Additionally, the submission is supported by data from ENZAMET, an Astellas-supported, investigator-sponsored Phase 3 research study led by the Australian and New ... or target action date, in Q4 2019 ... read more

Researchers identify key to controlling growth and progression of prostate cancer

To be more specific, it appears that HULLK controls the growth of prostate cancer cells. The researchers ... therapy has many side effects that some men do not want to experience. Gioeli's discovery ... read more

A new therapeutic target for metastatic and resistant prostate cancers

The study identifies a new vulnerability in aggressive, metastatic prostate cancers ... For these reasons, NSD2 represents an emerging therapeutic target against prostate cancer. To achieve these ... read more

Researchers Identify Protein Required for Breast Cancer Metastasis

The findings, which appear in the journal Cancer Research, may provide a new target ... therapy,” he added. Although these findings primarily focus on breast cancer and metastasis, the researchers ... read more

What is immunotherapy anyway? What you need to know about this exciting cancer treatment

A second major class of immunotherapeutics used to treat cancer are called monoclonal antibodies (mAbs), which target specific ... only one FDA-approved therapeutic vaccine, which is used to treat ... read more

FDA Approval for Darolutamide in Prostate Cancer

The approval was granted under the FDA's priority review and came 3 months ahead of the target ... metastasis or death from any cause within 33 weeks after the last evaluable scan, whichever occurs ... read more

Interim scan during therapy helps guide prostate cancer treatment, shows research

New prostate cancer research shows ... 177Lu-PSMA therapy has shown promising results in treating patients with metastatic castration-resistant prostate cancer. The therapy typically involves a ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us